Medication Treatment Patterns Following Initiation on Olanzapine versus Risperidone
The substantial burden of schizophrenia at the individual, family and community levels has been well documented.
Clin Drug Invest 22(11) 2002FDA Approves Aripiprazole for Schizophrenia
The US Food and Drug Administration (FDA) has approved aripiprazole for the treatment of schizophrenia, Bristol-Myers Squibb Co. and Japan's Otsuka Pharmaceutical Company Ltd. announced last Friday evening.
Reuters Health Information 2002